Home » Topics » BioWorld Science

BioWorld Science
RSS

PharmAbcine reports GLP toxicology results for TIE2-activating antibody PMC-403

April 27, 2022

Virpax reports preclinical PK results for VRP-324 for management of seizures

April 27, 2022

Algernon's NP-251 shown to reduce fibrosis in preclinical NASH study

April 27, 2022

NexImmune's AIM ACT to be studied in Columbia University's PDO models of HPV-associated cancers

April 27, 2022

ECCMID 2022: In antibiotic development, scientific ingenuity meets a dysfunctional marketplace

April 27, 2022

AstraZeneca presents new PROTACs for cancer

April 27, 2022

Cullgen identifies new PROTACs

April 27, 2022

Scorpion Therapeutics describes new EGFR and/or HER2 inhibitors

April 27, 2022

LYL-797, ROR1-targeted CAR T-cell candidate designed using reprogramming technologies

April 27, 2022

RaQualia Pharma patents CRF2 receptor antagonists

April 27, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...